Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Insulin-dependent diabetes may occur in patients with cancers who are treated with checkpoint inhibitors (CPIs). We reviewed cases occurring over a 6-year period at two academic institutions and identified 27 patients in whom this developed, or an incidence of 0.9%. The patients had a variety of sol...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamatouli, Angeliki M., Quandt, Zoe, Perdigoto, Ana Luisa, Clark, Pamela L., Kluger, Harriet, Weiss, Sarah A., Gettinger, Scott, Sznol, Mario, Young, Arabella, Rushakoff, Robert, Lee, James, Bluestone, Jeffrey A., Anderson, Mark, Herold, Kevan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Diabetes Symposium: Emerging Areas of Islet Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054443/
https://www.ncbi.nlm.nih.gov/pubmed/29937434
http://dx.doi.org/10.2337/dbi18-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054443/
https://www.ncbi.nlm.nih.gov/pubmed/29937434
http://dx.doi.org/10.2337/dbi18-0002

Ejemplares similares